Travel vaccination in senior travelers: current evidence, challenges, and prevention
Andrea Rossanese, Alberto Tomasi · 2026
Read Travel vaccination in senior travelers: current evidence, challenges, and prevention by Andrea Rossanese, Alberto Tomasi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13576279.txt.
Description
Andrea Rossanese and Alberto Tomasi review vaccination for older travelers in a 2026 paper. More seniors travel abroad, and their pre-trip care must weigh aging immunity, medicines, and exposure. Routine shots anchor the visit: flu, COVID-19, pneumococcal, RSV, shingles, and tetanus-diphtheria vaccines. Trip-specific shots, from hepatitis to rabies, depend on place, route, and time left.
Yellow fever vaccine needs special care, since age raises the risk of its rare severe reactions. New dengue and chikungunya vaccines call for case-by-case judgment too. Food, water, and insect precautions complete the shield. The authors note thin evidence for the frailest elders, who rarely join trials. They urge pre-travel care that is thorough, exposure-based, and fitted to each traveler. Prevention, in their telling, is a package, not a single shot.
Catalog record
| CREATOR | Andrea Rossanese, Alberto Tomasi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |